Clinical Trial Update: Oxytocin and Tibolone Adjuncts in Treatment Resistant Depression - A Pilot Study [Phase 1]

View source ↗

Summary

A Phase 1 pilot study evaluating oxytocin and tibolone as adjuncts for treatment-resistant depression; no results or current status are provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Oxytocin (Oxytocin)
• Tibolone (tibolone)

Snippet

Sponsor: The Alfred | Conditions: Depression, Major Depressive Disorder | Phase 1 | Status: UNKNOWN